Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis

[1] Djimdé AA(2008)Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali Am J Trop Med Hyg 78 455-461

[2] Fofana B(2009)Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Malar J 8 125-2209

[3] Sagara I(2009) malaria Malar J 8 48-1511

[4] Sidibe B(2007)The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Malar J 6 54-1021

[5] Toure S(2007)Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zerekore JAMA 297 2210-72

[6] Dembele D(2006)Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial Trop Med Int Health 11 1503-145

[7] Dama S(2006)Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes Trop Med Int Health 11 1017-1111

[8] Ouologuem D(2006)Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 in Kailahun, Sierra Leone Malar J 5 113-1086

[9] Dicko A(2002)Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Lancet 359 1365-492

[10] Doumbo OK(2006) malaria in the Republic of Congo Am J Trop Med Hyg 75 143-554

[1] Djimdé AA(2008)Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali Am J Trop Med Hyg 78 455-461

[2] Fofana B(2009)Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Malar J 8 125-2209

[3] Sagara I(2009) malaria Malar J 8 48-1511

[4] Sidibe B(2007)The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Malar J 6 54-1021

[5] Toure S(2007)Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zerekore JAMA 297 2210-72

[6] Dembele D(2006)Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial Trop Med Int Health 11 1503-145

[7] Dama S(2006)Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes Trop Med Int Health 11 1017-1111

[8] Ouologuem D(2006)Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 in Kailahun, Sierra Leone Malar J 5 113-1086

[9] Dicko A(2002)Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Lancet 359 1365-492

[10] Doumbo OK(2006) malaria in the Republic of Congo Am J Trop Med Hyg 75 143-554